Search for: "Boehringer-Ingelheim"
Results 161 - 180
of 443
Sorted by Relevance
|
Sort by Date
20 Aug 2012, 11:15 am
Since coming on the market in October 2010 the FDA has received numerous Adverse Event Reports involving: • Serious bleeding side effects • Hemorrhages such as hemorrhagic stroke In addition, some medical studies have associated Pradaxa with an increased risk: • Heart attack • Myocardial infarction (MI)• Acute coronary syndrome (ACS) Due to these serious side effects, a growing number of personal injury and wrongful death Pradaxa lawsuits have been filed against… [read post]
12 Apr 2023, 4:00 am
Sandoz Canada Inc., 2023 FC 243 at para 29. [6] See Boehringer Ingelheim (Canada) Ltd. v. [read post]
2 May 2012, 11:11 am
Pradaxa 260 Deaths Last year, Boehringer Ingelheim, acknowledged that since March 2008, it had received 260 reports of bleeding-related deaths in patients taking Pradaxa. [read post]
20 Aug 2012, 2:01 pm
These Pradaxa lawsuits were filed against Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, and Boehringer Ingelheim Vetmedica, Inc. [read post]
20 Aug 2012, 2:01 pm
These Pradaxa lawsuits were filed against Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, and Boehringer Ingelheim Vetmedica, Inc. [read post]
23 Jan 2015, 12:59 pm
Boehringer Ingelheim—the manufacturer of Pradaxa—has paid close to $650 million to resolve the thousands of cases brought against it due to the drug’s harmful bleeding side effects. [read post]
10 Oct 2017, 7:10 am
" Boehringer Ingelheim Pharmaceuticals, Inc. et al v. [read post]
24 Dec 2013, 5:49 am
” Boehringer Ingelheim Vetmedica, Inc. v. [read post]
13 Nov 2019, 9:15 am
Boehringer Ingelheim International GMBH, IPR2016-01563, Paper 16 (Feb. 3, 2017), that a relied-upon Glucophage label had no source identifying information or indicia of when it became publicly available and the declaration attesting to its publication was not based on personal knowledge, but was merely conclusory. [read post]
TTAB Test: Is "BREATHLESS" Merely Descriptive of Idiopathic Pulmonary Fibrosis Information Services?
29 Nov 2017, 3:29 am
In re Boehringer Ingelheim Pharmaceuticals, Inc., Serial No. 86852106 (November 27, 2017) [not precedential] (Opinion by Judge Frances Wolfson).The Board ignored applicant's feeble double entendre argument, but it agreed with applicant that the USPTO's evidence failed to show that the term "breathless" merely describes the subject services. [read post]
17 Nov 2015, 6:00 am
Normal results occurred 92% of the time, under controlled circumstances in the study from Boehringer Ingelheim. [read post]
23 Jan 2013, 4:16 pm
” Boehringer Ingelheim Vetmedica, Inc. v. [read post]
25 Aug 2015, 10:38 am
Boehringer Ingelheim Pradaxa Clinical Trial Data not shared with FDA In July 2014, the BMJ reported that the Pradaxa’s Boehringer Ingelheim failed to provide the FDA with important clinical trial data. [read post]
19 Nov 2013, 12:57 pm
This development might make it easier psychologically and economically for Boehringer Ingelheim to make this right and get these claims resolved. [read post]
26 Mar 2012, 2:09 pm
A devastating acknowledgment, however, by the German manufacturer of Pradaxa, Boehringer Ingelheim, notes that hundreds of deaths since 2010 may be the result of uncontrollable internal bleeding caused by Pradaxa. [read post]
15 Jan 2014, 2:20 pm
A Primary Focus Is Gastrointestinal And Intracranial Hemorrhages In Patients Using Pradaxa For Atrial Fibrillation (Posted by Tom Lamb at DrugInjuryWatch.com)Pradaxa, an anticoagulant drug from Boehringer Ingelheim, was approved by drug regulators in Europe in 2008 and later by the FDA in 2010. [read post]
29 Aug 2007, 10:22 am
Boehringer Ingelheim Vetmedica, Inc. (17-CA-22964; 350 NLRB No. 60) St. [read post]
3 Jun 2016, 10:50 am
“Boehringer Ingelheim to Settle 4,000 Pradaxa Lawsuits for $650 Million. [read post]
13 Oct 2011, 6:23 am
ISMP Quarterwatch 2010 4th Quarter: Hemorrhages And Thromboembolic Events Have Been Reported To FDA (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "Boehringer says about 260 deaths related to Pradaxa" (11/12/11, Reuters) FRANKFURT Nov 12 (Reuters) - Boehringer Ingelheim said that 260 cases of fatal bleeding have been linked to its new stroke prevention pill Pradaxa so… [read post]
25 Nov 2012, 1:00 pm
The CJEU in the reference -- Boehringer Ingelheim KG v Swingward Ltd [2007] ETMR 71 (Boehringer II) --did not follow the Advocate General's opinion. [read post]
